ERBB2 and neoplasm: Human epidermal growth factor receptors (HER) are among the most studied tyrosine kinase receptors that contribute to oncogenesis and tumor progression, consistent with the definition of EGFR (HER1) and HER2 as relevant tumor antigens (1, 2).